| Literature DB >> 25395912 |
Poonam Agrawal1, Varikasuvu Seshadri Reddy1, Himanshu Madaan1, Surajeet Kumar Patra2, Renu Garg1.
Abstract
Diabetes and urbanization are major contributors to increased risk factors of cardiovascular diseases. Studying whether atherogenic dyslipidaemia increases with urbanization in type 2 diabetes mellitus is, therefore, important. The sample of the present study consisted of 400 subjects. They were categorized according to residential area and diabetes into four groups: urban diabetic group, urban non-diabetic control group (from a metropolitan city Delhi), rural non-diabetic diabetic group, and rural control group (from villages of Khanpur Kalan, Sonepat, Haryana). Differences in lipid levels and risk factors of emerging cardiovascular diseases between groups were evaluated with analysis of variance. Diabetic patients of both urban and rural areas had significantly higher total cholesterol (TC), triglycerides (TG), very low-density lipoproteins (VLDL), TC to high-density lipoprotein cholesterol (TC/HDL) ratio, TG to high-density lipoprotein cholesterol (TG/HDL) ratio, and atherogenic index (AI) compared to respective controls (p<0.05). The HDL concentrations in urban diabetics were significantly lower (p<0.05) than in urban non-diabetic group and rural diabetic group. Comparison between urban and rural diabetic groups showed significantly higher atherogenic dyslipidaemia (AD) in the urban patient-group (p<0.05). We evaluated significant relationships of diabetes and urbanization with AD by multiple regression analysis. Receiver operating curve (ROC) analysis showed high area under curve (AUC) for TG/HDL in urban diabetic group (0.776, p<0.0001) and in rural diabetic group (0.692, p<0.0001). It is concluded that diabetes was associated with higher AD parameters. Urbanization in diabetes is also associated with elevated levels of AD, indicating higher risk in urban population. This study suggests that TG/HDL may be particularly useful as atherogenic risk predictor in newly-diagnosed type 2 diabetic patients.Entities:
Keywords: Atherogenic dyslipidaemia; Atherogenic index; Diabetes; India; Urbanization
Mesh:
Substances:
Year: 2014 PMID: 25395912 PMCID: PMC4221455
Source DB: PubMed Journal: J Health Popul Nutr ISSN: 1606-0997 Impact factor: 2.000
Biochemical characteristics of the study population
| Variable | Urban controls | Urban diabetics | Rural controls | Rural diabetics |
|---|---|---|---|---|
| FBS (mg/dL) | 88.94±10.50 | 148.39±38.22 | 91.05±11.77 | 162.80±57.24 |
| TC (mg/dL) | 202.54±43.30 | 219.05±51.56 | 199.74±44.19 | 222.46±56.62 |
| TG (mg/dL) | 157.63±66.50 | 218.65±85.38 | 157.33±67.62 | 215.42±84.48 |
| HDL (mg/dL) | 43.41±6.34 | 38.15±8.35 | 44.06±6.65 | 45.30±6.70 |
| LDL (mg/dL) | 126.09±44.24 | 132.64±52.99 | 126.31±44.59 | 131.21±50.12 |
| VLDL (mg/dL) | 31.42±13.32 | 43.81±17.11 | 31.45±13.56 | 43.14±16.92 |
| Non-HDL | 159.13±38.32 | 180.90±48.63 | 155.69±38.94 | 177.17±51.84 |
| TC/HDL | 4.65±0.61 | 5.90±1.48 | 4.51±0.60 | 4.89±0.80 |
| TG/HDL | 3.67±1.56 | 6.02±2.83 | 3.59±1.48 | 4.83±1.90 |
| LDL/HDL | 3.00±0.80 | 3.36±1.04 | 2.83±0.69 | 2.87±0.86 |
| Non-HDL/HDL | 3.65±0.61 | 4.90±1.48 | 3.51±0.60 | 3.89±0.80 |
| AI | 0.53±0.18 | 0.73±0.20 | 0.52±0.17 | 0.65±0.19 |
*p<0.05 between urban controls and urban diabetic groups;
¶p<0.05 between rural controls and rural diabetic groups;
§p<0.05 between urban and rural diabetic groups; AI=Atherogenic index; FBS=Fasting blood sugar; HDL=High-density lipoprotein; LDL=Low-density lipoprotein; Non-HDL=TC-HDL; TC=Total cholesterol; TG=Triglycerides; VLDL=Very low-density lipoprotein
Results of multiple regression analysis in the study population
| Dependent variable | Independent variable | |||||
|---|---|---|---|---|---|---|
| Diabetes | Urbanization | |||||
| β | SE of β | p | β | SE of β | p | |
| TC | 18.62 | 5.10 | 0.0003 | -1.54 | 5.28 | 0.76 |
| TG | 60.50 | 7.96 | <0.0001 | 2.68 | 8.24 | 0.74 |
| HDL | -2.32 | 0.76 | 0.0025 | -3.66 | 0.79 | <0.0001 |
| LDL | -2.60 | 5.02 | 0.60 | -1.13 | 5.20 | 0.82 |
| VLDL | 12.24 | 1.59 | <0.0001 | 0.49 | 1.65 | 0.76 |
| Non-HDL | 20.94 | 4.64 | <0.0001 | 2.11 | 4.80 | 0.65 |
| TC/HDL | 0.84 | 0.10 | <0.001 | 0.51 | 0.10 | <0.0001 |
| TG/HDL | 1.86 | 0.21 | <0.0001 | 0.62 | 0.22 | 0.005 |
| LDL/HDL | 0.18 | 0.09 | 0.038 | 0.27 | 0.093 | 0.0031 |
| Non-HDL/HDL | 0.84 | 0.10 | <0.0001 | 0.51 | 0.10 | <0.0001 |
| AI | 0.17 | 0.01 | <0.0001 | 0.05 | 0.02 | 0.017 |
AI=Atherogenic index; HDL=High-density lipoprotein; LDL=Low-density lipoprotein; Non-HDL=TC-HDL; SE=Standard error of coefficient; TC=Total cholesterol; TG=Triglycerides; VLDL=Very low-density lipoprotein; β=Coefficient; p=Statistical significance
Receiver operating characteristic curves for atherogenic lipid risk factors in urban and rural population
| Urban controls vs Urban diabetics | Variable | Rural controls vs Rural diabetics | ||||||
|---|---|---|---|---|---|---|---|---|
| ROC characteristics | ROC characteristics | |||||||
| p value | AUC | Sensitivity/ Specificity | Criterion | Criterion | Sensitivity/ Specificity | AUC | p value | |
| 0.0012 | 0.628 | 81/44 | >145 | Non-HDL | >141 | 79/43 | 0.622 | 0.0044 |
| <0.0001 | 0.775 | 59/90 | >5.4 | TC/HDL | >4.4 | 74/48 | 0.637 | 0.0014 |
| <0.0001 | 0.776 | 76/74 | >4.1 | TG/HDL | >5.0 | 51/87 | 0.692 | <0.0001 |
| 0.0011 | 0.632 | 52/74 | >3.2 | LDL/HDL | >2.7 | 62/54 | 0.520 | 0.671 |
| <0.0001 | 0.775 | 59/90 | >4.4 | Non-HDL/HDL | >3.4 | 74/48 | 0.637 | 0.0014 |
| <0.0001 | 0.775 | 76/74 | >0.61 | AI | >0.60 | 52/85 | 0.691 | <0.0001 |
AI=Atherogenic index; AUC=Area under curve; HDL=High-density lipoprotein; LDL=Low-density lipoprotein; Non-HDL=TC-HDL; TC=Total cholesterol; TG=Triglycerides; VLDL=Very low-density lipoprotein; p=Statistical significance
Figure 1.Comparison of receiver operating curve analysis of atherogenic lipid risk factors, showing high area-under-curve value for TG/HDL-C (AUC 0.776, p<0.0001, criterion value >4.1) in urban diabetic group
Figure 2.Comparison of receiver operating curve analysis of atherogenic lipid risk factors, showing high area-under-curve value for TG/HDL-C (AUC 0.692, p <0.0001, criterion value >5.0) in rural diabetic group